Everyone blames management and calls it a wonder drug. I disagree on missed opportunities statement. By the way I am not sticking up for management. One has been worse than the other. First the U S. Cant blame management there. Revenues uptake was excellent and would have continued. Drug was a huge success Yes they absolutely screwed up with the patent. Paying off apotec and teva while leaving hikma and reddy out was just a total waste of money and beyond stupid.. Only takes one to file anda and then amrn has to sue. Canada has been aproved for 6 years and is a total disaster. So I guess it is HLS management fault. Also they partnered with Pfizer. That was such a disaster that hls cancelled it. I guess Pfizer had bad management also. EU been approved for 5 years and still near zero revenues. Cant even get approved in germany and italy. So now we will blame that on amarin management. China . Edding could not get reimbursement. Again they must have bad management. Just possibly other than the U S which had a great launch the rest of the worlds universal govt paid healthcare has zero interest in the drug and it is not amarin, HLS, PFE or eddings fault
Market Data 
Markets 
AI
